Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)

News | Pharmaceuticals

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

July 10, 2024

Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.

News | AHA

American Heart Association Announces New 2024-2025 National Volunteer Leaders

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

July 09, 2024

Counties tend to be more rural and socioeconomically disadvantaged

News | Cardiovascular Business

Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

July 09, 2024

Feature | Cardiovascular Business

Happy 4th from the DAIC team

The DAIC team wishes you a safe and happy 4th of July!

July 04, 2024

Researchers call for monitoring of quality, outcomes in era of private equity ownership

News | Cardiovascular Business

Study: Private Equity Acquisitions in Cardiology on the Rise

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

July 03, 2024

Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions

News | Structural Heart

Cedars-Sinai Cardiologist Leads the American Society of Transplantation

July 3, 2024 — Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the ...

July 03, 2024

Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels

News | FDA

FDA Issues Left Ventricular Assist System (LVAS) Monitor Correction: Abbott Issues Correction for HeartMate LVAS System Monitor due to Screen Issues that May Cause Unintentional Pump Stop

July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...

July 02, 2024

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

DAIC's Top 10 for June

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June:

1. Med ...

July 02, 2024

Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer

News | Cardiovascular Business

CVRx Announces Key Senior Leadership Team Hires

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

July 01, 2024

The program aims to improve health outcomes, with a focus on increasing awareness of the symptoms and risks of hypertension

News | Hypertension

Expansion of AstraZeneca’s Flagship Health Equity Program Healthy Heart Africa

June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...

June 28, 2024

Jodie L. Hurwitz, MD, FHRS, and Kenneth A. Ellenbogen, MD, FHRS.

News | Cardiovascular Business

Change in HRS Board of Trustees

June 28, 2024 — After a year of dedicated service and outstanding leadership, Jodie L. Hurwitz, MD, FHRS, has now ended ...

June 28, 2024

Partially calcified valve leaflet tissue, including unaltered collagen (blue), calcified collagen (yellow to red) and aggregated calcium phosphate nodules.

News | Heart Failure

Study Defines the Process of and Defenses Against Cardiac Valve Calcification

June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...

June 27, 2024

Study lays the foundation for more research into the potential role of screening in the elderly population

News | Heart Valve Technology

More than a Quarter of ‘Healthy’ Over-60s Have Heart Valve Disease, According to New Research

June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...

June 27, 2024

New analysis by the American Heart Association and the McKinsey Health Institute reveals the burden of cardiovascular disease for women in the U.S. and proposes solutions to improve care

News | Womens Cardiovascular Health

Gender Gaps in Cardiovascular Disease Diagnosis and Treatment Persist

June 27, 2024 — Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist ...

June 27, 2024

The Society of Cardiovascular Computed Tomography (SCCT) 19th annual scientific meeting, SCCT24, will be held July 18-21, in Washington, DC.

Feature | SCCT | by Christine Book

Society of Cardiovascular Computed Tomography Annual Scientific Meeting SCCT24 Preview

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual ...

June 27, 2024